ASXL1 is over-expressed in 88.9% of 20q11.21 amplified colorectal cancers in the TCGA cohort, while POFUT1 is over-expressed in 90.5% of 20q11.21 amplified cases in the same cohort [7]. Here, ASXL1 is linked to colorectal cancer.